LRMR
Larimar Therapeutics, Inc. Common Stock
Nasdaq · usd
Larimar Therapeutics, Inc. Common Stock (LRMR) trades at $2.39 (+3.02%) as of 7:57:45 PM EST on Nov 6, 2026, -11.48% over the past month. Market cap is $248.28M, with 8.9 days to cover in short interest.
Stock performance
How Larimar Therapeutics, Inc. Common Stock (LRMR) stock has performed from one day to one year, with its 52-week range.
- 1D
- +3.02%
- 1W
- -3.24%
- 1M
- -11.48%
- YTD
- -37.27%
- 1Y
- -32.68%
- 52-wk range
- $1.92 – $6.42
Key statistics
Today's trading snapshot for LRMR: day range, open, previous close, volume and market cap.
- Day range
- $2.30 – $2.48
- Open
- $2.36
- Prev close
- $2.32
- Volume
- 973.64K
- Market cap
- $248.28M
- Shares out
- 103.88M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Larimar Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 1.95
- P/FCF
- —
- ROE
- -135.5%
- ROA
- -104.4%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 6, 2026
8-K filings
Material corporate events Larimar Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Executive compensation changeSep 29, 2026
The Employment Agreement provides for an initial base salary of $560,000 per annum, which is subject to annual review and adjustment by the Compensation Committee of the Board (the "Compensation Committee"). In addition, Mr. Harlow will receive a cash signing bonus of $35,000 and is eligible to earn an annual bonus with a target amount equal to 40% of his annual base salary.
- Investor presentationAug 4, 2026
On August 4, 2026, the Company posted on its website an updated slide presentation... Representatives of the Company will use the presentation in various meetings with investors, analysts and other parties from time to time.
- Investor presentationJun 29, 2026
the Company will host a conference call to discuss a regulatory update and use a slide presentation in conjunction with the call. A copy of the presentation is filed herewith as Exhibit 99.2
- Charter amendmentMay 19, 2026
The stockholders approved an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's Common Stock from 115,000,000 to 215,000,000.
- Investor presentationMay 14, 2026
On May 14, 2026, the Company posted on its website an updated slide presentation, which is attached as Exhibit 99.2 to this Current Report on Form 8-K. Representatives of the Company will use the presentation in various meetings with investors, analysts and other parties from time to time.
LRMR short interest
How heavily LRMR is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 8.9
- Short interest
- 14.66M
- Avg volume
- 1.64M
As of · reported to FINRA twice monthly.
LRMR news
The latest news and headlines about Larimar Therapeutics, Inc. Common Stock (LRMR).
- Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerpositiveZacks Investment Research· Oct 5, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMRnegativeGlobeNewswire Inc.· Jul 7, 2026
- Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public OfferingpositiveBenzinga· Feb 25, 2026
- Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public OfferingpositiveGlobeNewswire Inc.· Feb 25, 2026
- Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMRnegativeBenzinga· Oct 16, 2025
Frequently asked questions
What is the Larimar Therapeutics, Inc. Common Stock (LRMR) stock price today?
Larimar Therapeutics, Inc. Common Stock (LRMR) is trading at $2.39 (+3.02% on the day) as of 7:57:45 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Larimar Therapeutics, Inc. Common Stock?
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform.
What is the short interest in LRMR?
As of Oct 15, 2026, LRMR has 14.66M shares short and 8.9 days to cover.
What exchange is LRMR listed on?
Larimar Therapeutics, Inc. Common Stock (LRMR) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of LRMR with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LRMR analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.